Vincerx Pharma, Inc. (VINC)

OTCMKTS · Delayed Price · Currency is USD
0.0128
+0.0002 (2.00%)
At close: Feb 26, 2026
-98.84%
Market Cap 66.74K
Revenue (ttm) n/a
Net Income (ttm) -22.65M
Shares Out 5.23M
EPS (ttm) -8.98
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 553
Average Volume 5,033
Open 0.0128
Previous Close 0.0125
Day's Range 0.0128 - 0.0128
52-Week Range 0.0002 - 1.4300
Beta 1.57
RSI 51.62
Earnings Date Mar 27, 2026

About Vincerx Pharma

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States. Its VersAptx bioconjugation platform combines different targeting, linker, and payload technologies to develop antibody-drug conjugates (ADC) and small molecule drug conjugates (SMDC); and provides CellTrapper technology for use in reduction of payload cellular permeability. The company develops VIP943, an antibody drug conjugate in Phase 1 d... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 13
Stock Exchange OTCMKTS
Ticker Symbol VINC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.